$6.355
-0.093 (-1.47%)Zum Schluss
Profitabilität und Margen von LFVN
Evaluating the bottom line, LifeVantage Corp maintains a gross margin of 77.97%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.93%, while the net margin is 3.02%. These profitability ratios, combined with a Return on Equity (ROE) of 14.87%, provide a clear picture of how effectively LFVN converts its operational activities into shareholder value.
LFVN im Vergleich zur Peergroup
In the context of the broader market, LFVN competes directly with industry leaders such as UPXI and IBIO. With a market capitalization of $79.61M, it holds a significant position in the sector. When comparing efficiency, LFVN's gross margin of 77.97% stands against UPXI's 93.11% and IBIO's N/A. Such benchmarking helps identify whether LifeVantage Corp is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von LifeVantage Corp
LifeVantage reported a revenue of $42.4 million for Q4 2026, a 23.1% year-over-year decline, and a gross margin of 77.97%.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.